Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Cady RK et al. – Elevation of saliva calcitonin gene–related peptide (CGRP) is predictive of responsiveness to rizatriptan. In the rizatriptan responsive population, CGRP levels are elevated beginning with the premonitory period and throughout mild and moderate/severe headache. Successful response to rizatriptan correlated with return of saliva CGRP levels to near baseline (interictal) values.

Related Articles

New drugs for migraine
The Journal of Headache and Pain, 10/05/09    Relevance Score: 88%

Study Could Change How Migraines are Diagnosed
Internet Source, 10/02/09    Relevance Score: 88%

Expanding Access to Triptans: Assessment of Clinical Outcome
Headache: The Journal of Head and Face Pain, 10/12/09    Relevance Score: 80%

Calcitonin gene-related peptide, adrenomedullin and flushing
Maturitas, 10/16/09    Relevance Score: 79%

Topiramate in migraine progression
The Journal of Headache and Pain, 10/21/09    Relevance Score: 69%

Today in Pain Management...keeping you current

Efficacy and safety of a single intrathecal methylprednisolone bolus in chronic complex regional pain syndrome
European Journal of Pain, 12/18/09

A randomised comparison of regular oral oxycodone and intrathecal morphine for post-caesarean analgesia
International Journal of Obstetric Anesthesia , 12/18/09

Increased pain sensitivity in alcohol withdrawal syndrome
European Journal of Pain, 12/18/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address